Good points Ice.
Re Immuno, it is more accurate to say that StarBright have offered (but still no deal done yet... I really want to know why) to provide $18m for further research in exchange for a share of the immuno rights. AHZ isn't "selling" it for $18 million. It's a subtle but important difference. It won't help the cash issue at all.
I share the view that they need to announce some good news, and a lot of it. I am not sure they actually will though. Who knows. They are burying news in 4cs now and it is all a bit strange to be honest. Twitter dead. No announcements. No communication.
Realistic overtake price, page-61
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |